Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | CES2 | O00748 | 3/20 | 0.51 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9545188 | 1.00 | ICMT (0.53) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL9545182 | 1.00 | ICMT (0.53) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL9119016 | 1.00 | ICMT (0.53) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL19927710 | 1.00 | ICMT (0.53) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL19927712 | 1.00 | ICMT (0.53) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL4953347 | 0.93 | ICMT (0.49) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL23117309 | 0.92 | ICMT (0.50) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL9275572 | 0.92 | ICMT (0.50) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL23117307 | 0.92 | ICMT (0.50) | ICMTMAPTCES2THRBBLM | |
| SCHEMBL9275581 | 0.92 | ICMT (0.50) | ICMTMAPTCES2THRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995034303-A1 | METHOD FOR THE TREATMENT, PREVENTION OR MINIMIZATION OF HAIR LOSS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-12-21 | — | — | WO | claimed |
| WO-1995000136-A1 | METHOD FOR TREATING HYPERKERATOSIS AND DISEASES MEDIATED BY PROTEASES | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-01-05 | — | — | WO | claimed |
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | VYOME THERAPEUTICS LIMITED (IN) | 2021-03-25 | — | — | US | disclosed |
| US-20200140460-A1 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | VYOME BIOSCIENCES PVT. LTD. (IN) | 2020-05-07 | — | — | US | disclosed |
| US-10570152-B2 | Antibacterial therapeutics and prophylactics | VYOME THERAPEUTICS LIMITED (IN) | 2020-02-25 | — | — | US | disclosed |
| EP-3507325-A2 | COMPOUNDS, COMPOSITONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | Vyome Therapeutics Limited (IN) | 2019-07-10 | — | — | EP | disclosed |
| US-20180265523-A1 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | VYOME THERAPEUTICS LIMITED (IN) | 2018-09-20 | — | — | US | disclosed |
| EP-3328856-A2 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | Vyome Biosciences Pvt. Ltd. (IN) | 2018-06-06 | — | — | EP | disclosed |
| WO-2018042367-A2 | COMPOUNDS, COMPOSITONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | VYOME BIOSCIENCES PVT. LTD. (IN) | 2018-03-08 | — | — | WO | disclosed |
| WO-2017017631-A2 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | VYOME BIOSCIENCES PVT. LTD. (IN) | 2017-02-02 | — | — | WO | disclosed |
| WO-1995034303-A1 | METHOD FOR THE TREATMENT, PREVENTION OR MINIMIZATION OF HAIR LOSS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180265523-A1 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | CLPP, CFTR, ELANE | ICMT 1794/4885MAPT 3826/4885CES2 3133/4885 |
| US-20200140460-A1 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | CLPP, CFTR, ELANE | ICMT 1794/4885MAPT 3826/4885CES2 3133/4885 |
| US-10570152-B2 | Antibacterial therapeutics and prophylactics | CLPP, CFTR, ELANE | ICMT 1794/4885MAPT 3826/4885CES2 3133/4885 |
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | CUTA, GMPS, MMP8 | ICMT 1810/4885MAPT 3659/4885CES2 2690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.